Patient’s adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy?
Crossref DOI link: https://doi.org/10.1186/s12894-015-0090-x
Published Online: 2015-09-21
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cindolo, Luca
Pirozzi, Luisella
Sountoulides, Petros
Fanizza, Caterina
Romero, Marilena
Castellan, Pietro
Antonelli, Alessandro
Simeone, Claudio
Tubaro, Andrea
de Nunzio, Cosimo
Schips, Luigi
License valid from 2015-09-21